Approximately 50% of Helicobacter pylori isolates produce a cytotoxin in vitro that induces vacuolation of eukaryotic cells. To determine the in vivo relevance of this phenomenon, we sought to detect cytotoxin-neutralizing antibodies in sera from H. pylori-infected persons. As a group, sera from 29 H. pyloriinfected patients neutralized the activity of the purified cytotoxin to a significantly greater extent than sera from 24 uninfected persons (P = 0.007). The cytotoxin neutralizing activity in sera from H. pylori-infected persons was mediated predominantly by the purified IgG fraction. Sera from H. pylon-infected persons neutralized the cytotoxins produced by multiple H. pylori strains, but failed to neutralize trimethylamine-induced cell vacuolation. Neutralization of cytotoxin activity by human or immune rabbit sera was associated with immunoblot IgG recognition of an 87-kD H. pylori protein. Similarly, neutralization of the toxin by sera was associated with IgG recognition of the purified cytotoxin in an enzyme-linked immunosorbent assay (P < 0.0001). The presence of cytotoxin-neutralizing antibodies in sera from H. pylori-infected persons indicates that the cytotoxin is synthesized in vivo. (J. Clin. Invest. 1992. 90:913-918.)
Introduction
Helicobacterpylori infection is now recognized as the predominant cause of chronic gastritis in humans, and is strongly associated with peptic ulcer disease ( 1, 2) . The pathogenic mechanisms whereby H. pylori causes human disease remain poorly understood. One potential determinant ofvirulence is a vacuolating cytotoxin that is detectable in broth culture supernatants from -50% of H. pylori strains (3) (4) (5) . In vitro, this toxin induces vacuolation of multiple eukaryotic cell types (4) . The vacuolating cytotoxin ofH. pylori is distinct from urease, but is potentiated by urease-mediated ammonia production (6) . Recently, the cytotoxin has been purified, and migrates as an 87-kD band under denaturing conditions (7) .
The role of the H. pylori-vacuolating cytotoxin in vivo has not yet been studied in detail. In gnotobiotic piglets experimentally infected with H. pylori, challenge with a toxigenic strain results in significantly more gastric epithelial vacuolation than challenge with a nontoxigenic strain (8) , which suggests that the cytotoxin is active in vivo. Several histopathologic studies have identified vacuoles in the gastric epithelial cells ofhumans infected with H. pylori (9) (10) (11) . However, it is not known whether these vacuoles form in response to H. pylori cytotoxin, ammonia, or other factors. Patients infected with a variety of noninvasive toxigenic bacteria, including Vibrio cholerae, enterotoxigenic Escherichia coli, and Clostridium difficile, mount neutralizing antibody responses to the toxins produced by these organisms ( 12, 13) . Therefore, to study further the in vivo relevance of H. pylori vacuolating cytotoxin activity, we sought to detect cytotoxin-neutralizing antibodies in sera from H. pylori-infected persons.
Methods
Bacterial strains and source ofvacuolating cytotoxin. Concentrated H. pylori culture supernatants were prepared by culturing the organism for 48 h in Brucella broth containing 5% fetal bovine serum, centrifuging the culture, and concentrating the cell-free supernatant by ultrafiltration, as described previously (6) . Concentrated supernatants from H. pylori strains 60190, 87-199, and 87-29 each induced vacuolation of HeLa cells in vitro (3). Vacuolating cytotoxin was purified from H. pylori 60190 by sequential column chromatography, as described previously (7).
Preparation of antisera. White New Zealand rabbits were immunized with concentrated supernatant from H. pylori 60190 (tox+) or supernatant from H. pylori Tx3Oa (tox-) (3) . The reactivity of these sera with H. pylori antigens has been described previously (3) .
Source of human sera. We studied H. pylori-infected and uninfected persons from two population groups. The first group consisted of 16 asymptomatic laboratory workers. Based on the results ofa standardized enzyme-linked immunosorbent assay (ELISA) that assayed serum IgG reactivity with a pool of sonicated H. pylori strains ( 14) , eight of these persons were infected with H. pylori and eight were not. The mean ages of the eight infected and eight uninfected persons were 38.0±1.3 and 34.5±3.6 yr, respectively. Ofthe eight workers who were H. pylori infected, six were born outside the United States, whereas all of the uninfected workers were born within the United States. This observation is consistent with data from another study, in which foreign place of birth was associated with an increased prevalence of H. pylori infection ( 15) .
The second group consisted ofsymptomatic patients who had previously undergone gastroduodenal endoscopy at the University Hospital and the Veterans Affairs Medical Center, Syracuse, NY. These patients were classified as H. pylori-infected or uninfected based on Giemsa staining and urease testing of gastric biopsy samples (CLO test, Delta West Limited, Weston, Australia), and evaluation of sera by ELISA (14) . For ( 14) . The ( 16) .
ELISA. Human sera were tested for reactivity with the purified cytotoxin in an ELISA, as described previously (7 Reciprocal serum dilution Figure 1 . Neutralization of H. pyloni cytotoxin activity by rabbit antiserum. White New Zealand rabbits were immunized with culture supernatant from H. pyloni 60190 (tox') or Tx3Oa (tox-). The preimmune and immune sera were then tested for cytotoxin-neutralizing activity. The net optical density produced by supernatant from H. pyloni 60190 in this experiment is indicated by the dashed line ----). At dilutions of 1:2 to 1:128, serum from the rabbit immunized with tox + H. pyloni supernatant neutralized cytotoxin activity significantly better than preimmune serum (P < 0.05). The neutralizing activities did not differ in preimmune and immune sera from the rabbit immunized with tox -supernatant. Reciprocal serum dilution Figure 2 pylori cytotoxin. IgG-mediated neutralization ofcytotoxin activity. To determine whether the cytotoxin-neutralizing activity in human sera was antibody mediated, IgG was purified from the sera of five asymptomatic infected and five uninfected persons, using a MAb Trap G column. The cytotoxin-neutralizing activity of whole sera from these persons is shown in Fig. 4 (top) . At a protein concentration of 12.5 mg/ml, the sera from the infected persons showed significantly greater neutralizing activity than sera from uninfected persons (P = 0.03). Purified IgG from the sera ofeach ofthe five infected persons neutralized H. pylori cytotoxin activity, whereas IgG from the 5 uninfected persons did not (Fig. 4, middle) pylori 60190 was immunoblotted with sera from the eight asymptomatic H. pylori-infected persons described previously, as well as with the immune rabbit serum that neutralized cytotoxin activity (Fig. 5) . The antigen used in these Western blotting studies was prepared by culturing H. pylori 60190 in Brucella broth containing 0.5% charcoal for 48 h; after centrifugation, the supernatant was concentrated 30-fold by precipitation with a 50% saturated solution ofammonium sulfate. The three human sera with the strongest neutralizing activity (Al, W1, and K I) all strongly recognized an 87-kD band, which was also recognized by rabbit antisera to tox+ H. pylori supernatant. Thus, high-titer cytotoxin-neutralizing activity in human or rabbit sera was associated with the presence of IgG antibodies to an 87-kD protein.
Neutralization ofthe purified H. pylori cytotoxin by human sera. The vacuolating cytotoxin has recently been purified to homogeneity from H. pylori culture supernatant, and migrates as an 87-kD band under denaturing conditions (7) . To study further the neutralization of vacuolating cytotoxin activity by human sera, we tested sera from 53 well-characterized patients for the capacity to neutralize the activity of the purified cytotoxin. Owing to limited quantities of sera available, cytotoxin neutralization was assessed using only a 1:8 dilution of sera. The net optical density produced by the purified cytotoxin alone was 0.276±0.04. The mean net optical densities produced by purified cytotoxin after preincubation with sera from 29 infected or 24 uninfected persons were 0.002±0.01 and 0.045±0.01, respectively (P = 0.007, Student's t test). Thus, sera from both groups of patients neutralized cytotoxin activity, but sera from H. pylori-infected persons as a group neutralized to a significantly greater extent than sera from uninfected persons. The cytotoxin neutralizing activity of seven (24%) of the sera from the 29 infected persons was significantly ( Protein Conco Figure 4 . Neutralization of H. pylor man sera, serum IgG, and sera after from the sera of five asymptomatic and five uninfected persons (o) usi whole sera (top), purified IgG (mia IgG (bottom) were then tested for c! net optical density produced by sup alone is indicated by the dashed lin the five H. pylori-infected persons c activity, whereas IgG from uninfect of IgG, sera from infected and uninf ized cytotoxin activity to similar del SD) greater than the mean neutralizing activity of sera from uninfected persons, whereas none ofthe sera from the 24 unin-
fected persons produced this degree of neutralization (P T = 0.01,Fisher's exact test).
Association between cytotoxin neutralization and ELISA i\ T \1 reactivity with the purified cytotoxin. To determine the preva-* lence of IgG antibodies to the cytotoxin, sera from the 53 pal tients described above were tested in an ELISA for reactivity with the purified cytotoxin, prepared by sequential column chromatography as described previously (7) (Fig. 6, top) . The mean reactivity of sera from H. pylori-infected persons with I I the purified cytotoxin was significantly greater than that ofsera fied toxin by sera from 18 (62%) ofthe 29 infected persons was significantly (> 2 SD) greater than the mean optical density i cytotoxin activity by whole huvalue produced by sera from the 24 uninfected persons. To removal of IgG. IgG was purified determine the relationship between neutralization of the puri-H. pylori-infected persons (-) fied toxin in the previous experiment and IgG reactivity with ing a MAbTrap G column. The the purified toxin in the ELISA, a linear regression analysis was Idle), and sera after removal of performed (Fig. 6, bottom) . For sera from H. pylori-infected ytotoxin-neutralizing activity. The lernatant from H. pylori 60190 persons, a significant relationship was present (P < 0.0001, r ie. The purified serum IgG from = 0.734). Interestingly, for sera from uninfected persons, a simompletely neutralized cytotoxin ilar but less significant trend was observed (P = 0.003, r Led persons did not. After removal = 0.583). These data indicate a strong relationship between Sected persons partially neutralneutralization ofthe purified cytotoxin and IgG reactivity with grees.
the purified cytotoxin. 916 Cover et al. ELISA optical density Figure 6 . Association between cytotoxin neutralizing activity and serologic recognition of the purified cytotoxin. Sera from 29 H. pylori-infected persons and 24 uninfected persons were tested in an ELISA for IgG reactivity with the purified cytotoxin. (Top) As a group, the reactivity of sera from H. pylori-infected persons was significantly greater than that of sera from uninfected persons (mean optical densities 0.930±0.110 vs. 0.287±0.023, P < 0.0001). (Bottom) The IgG reactivity ofsera from the 29 H. pylori-infected persons with the purified cytotoxin in an ELISA was significantly associated with neutralization of cytotoxin activity in the cell culture assay (P < 0.0001, r = 0.734 by linear regression analysis).
Discussion
Although the majority of persons infected with H. pylori are asymptomatic, infection is a risk factor for the development of peptic ulceration ( 1, 2) and possibly gastric carcinoma (18) (19) (20) . One of the determinants that may contribute to the virulence ofH. pylori infection is a cytotoxin that induces vacuolation of eukaryotic cells (3, 4) . The cytotoxin has recently been purified, and corresponds to an 87-kD band visualized by SDS-PAGE under denaturing conditions (7) . Based on detection in a cell culture assay, approximately 50-60% ofH. pylori strains produce the cytotoxin in vitro (3) (4) (5) . Two studies have demonstrated that patients with duodenal ulceration are more commonly infected with cytotoxin-producing H. pylori strains than infected patients with gastritis only (21, 22) . To determine whether the vacuolating cytotoxin is produced by H. pylori in vivo, we sought to detect neutralizing antibodies to the cytotoxin in sera from H. pylori-infected persons.
In this study, cytotoxin neutralizing activity was detectable in sera from H. pylori-infected humans in serum dilutions ranging from 1:2 to 1:16, and significantly greater cytotoxinneutralizing activity was present in sera from H. pylori-infected persons than in sera from uninfected persons. These data are consistent with the results of Leunk et al. (23) , who reported neutralization of H. pylori cytotoxin activity by human sera diluted in a range from 1:2 to 1:64. In this study, we have demonstrated that cytotoxin activity is neutralized by the purified IgG fraction of sera from H. pylori-infected but not uninfected persons. Vacuolating cytotoxin activity was also partially neutralized by human sera after removal of IgG. The presence of the latter activity in sera from both H. pylori-infected and uninfected persons suggests that this effect is not mediated by H. pylori-specific antibodies. This phenomenon may be mediated by a variety of serum components, including amino acids and hormones, which are known to inhibit autophagic vacuole formation and cellular protein degradation (24) (25) (26) .
The current study has demonstrated that neutralization of vacuolating cytotoxin activity by human sera is associated with the presence of IgG antibodies to the purified H. pylori cytotoxin. We speculate that the presence ofneutralizing antibodies to the cytotoxin reflects current or recent infection with a tox + H. pylori strain. Based upon detection in the cell culture assay, 24% of sera from H. pylori-infected persons contained cytotoxin neutralizing antibodies. In contrast, IgG reactivity with the purified cytotoxin in an ELISA was demonstrated for 62% of the sera from H. pylori-infected persons. These data suggest that the ELISA is a more sensitive method for detecting anticytotoxin antibodies than the neutralization assay. The recognition of cytotoxin in the ELISA by sera from 62% of H. pyloriinfected persons may be interpreted as evidence for cytotoxin production in vivo by this proportion of strains; a similar proportion ofstrains produce detectable cytotoxin activity in vitro (3, 4) .
It is notable that a weaker relationship between cytotoxin neutralization and ELISA reactivity with the purified cytotoxin was observed among sera from uninfected persons. This phenomenon suggests that the vacuolating cytotoxin may have a weak antigenic relationship with an antigen to which all persons are commonly exposed. There is partial homology between the amino-terminal sequence of the H. pylori cytotoxin and several bacterial transport or ion channel proteins (7); such proteins are potential candidates for this antigenic similarity.
In conclusion, the presence of cytotoxin-neutralizing antibodies in sera from persons infected with H. pylori provides strong evidence that the cytotoxin is produced in vivo. It is not yet known whether the cytotoxin of H. pylori plays an important role in the pathogenesis of infection, or whether neutralizing antibodies to the cytotoxin modulate the course of infection. In the future, these questions may be studied in animal models, using isogenic H. pylori strains differing only in cytotoxin activity, or by studies involving immunization with the cytotoxin.
